ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients

Abstract Background Transient and persistent acute kidney injury (AKI) could share similar physiopathological mechanisms. The objective of our study was to assess prognostic impact of AKI duration on ICU mortality. Design Retrospective analysis of a prospective database via cause-specific model, wit...

Full description

Bibliographic Details
Main Authors: A. S. Truche, S. Perinel Ragey, B. Souweine, S. Bailly, L. Zafrani, L. Bouadma, C. Clec’h, M. Garrouste-Orgeas, G. Lacave, C. Schwebel, F. Guebre-Egziabher, C. Adrie, A. S. Dumenil, Ph. Zaoui, L. Argaud, S. Jamali, D. Goldran Toledano, G. Marcotte, J. F. Timsit, M. Darmon
Format: Article
Language:English
Published: SpringerOpen 2018-12-01
Series:Annals of Intensive Care
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13613-018-0467-6
id doaj-67701136591047eab1bdf8f4a7821487
record_format Article
spelling doaj-67701136591047eab1bdf8f4a78214872020-11-25T02:54:00ZengSpringerOpenAnnals of Intensive Care2110-58202018-12-018111110.1186/s13613-018-0467-6ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patientsA. S. Truche0S. Perinel Ragey1B. Souweine2S. Bailly3L. Zafrani4L. Bouadma5C. Clec’h6M. Garrouste-Orgeas7G. Lacave8C. Schwebel9F. Guebre-Egziabher10C. Adrie11A. S. Dumenil12Ph. Zaoui13L. Argaud14S. Jamali15D. Goldran Toledano16G. Marcotte17J. F. Timsit18M. Darmon19UMR 1137 - IAME Team 5 – DeSCID : Decision SCiences in Infectious Diseases, Control and Care, Inserm/Paris Diderot University, Sorbonne Paris CitéMedical Intensive Care Unit, Croix Rousse Hospital, Lyon University HospitalMedical Intensive Care Unit, Gabriel Montpied University HospitalUMR 1137 - IAME Team 5 – DeSCID : Decision SCiences in Infectious Diseases, Control and Care, Inserm/Paris Diderot University, Sorbonne Paris CitéMedical Intensive Care Unit, AP-HP, Saint Louis HospitalMedical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat Hospital, Paris Diderot UniversityIntensive Care Unit, AP-HP, Avicenne HospitalIntensive Care Unit, Saint Joseph Hospital NetworkMedical Intensive Care Unit, André Mignot HospitalMedical Intensive Care Unit, Grenoble University HospitalNephrology Dialysis Renal Transplantation, Grenoble University HospitalPhysiology Department, Cochin University Hospital, Assistance Publique, Hôpitaux de Paris (AP-HP), Paris Descartes University des, Sorbonne CiteMedical-Surgical Intensive Care Unit, AP-HP, Antoine Béclère University HospitalNephrology Dialysis Renal Transplantation, Grenoble University HospitalMedical Intensive Care Unit, Edouard Herriot University HospitalCritical Care Medicine Unit, Dourdan HospitalIntensive Care Unit, Gonesse HospitalSurgical ICU, Edouard Herriot University HospitalUMR 1137 - IAME Team 5 – DeSCID : Decision SCiences in Infectious Diseases, Control and Care, Inserm/Paris Diderot University, Sorbonne Paris CitéMedical Intensive Care Unit, AP-HP, Saint Louis HospitalAbstract Background Transient and persistent acute kidney injury (AKI) could share similar physiopathological mechanisms. The objective of our study was to assess prognostic impact of AKI duration on ICU mortality. Design Retrospective analysis of a prospective database via cause-specific model, with 28-day ICU mortality as primary end point, considering discharge alive as a competing event and taking into account time-dependent nature of renal recovery. Renal recovery was defined as a decrease of at least one KDIGO class compared to the previous day. Setting 23 French ICUs. Patients Patients of a French multicentric observational cohort were included if they suffered from AKI at ICU admission between 1996 and 2015. Intervention None. Results A total of 5242 patients were included. Initial severity according to KDIGO creatinine definition was AKI stage 1 for 2458 patients (46.89%), AKI stage 2 for 1181 (22.53%) and AKI stage 3 for 1603 (30.58%). Crude 28-day ICU mortality according to AKI severity was 22.74% (n = 559), 27.69% (n = 327) and 26.26% (n = 421), respectively. Renal recovery was experienced by 3085 patients (58.85%), and its rate was significantly different between AKI severity stages (P < 0.01). Twenty-eight-day ICU mortality was independently lower in patients experiencing renal recovery [CSHR 0.54 (95% CI 0.46–0.63), P < 0.01]. Lastly, RRT requirement was strongly associated with persistent AKI whichever threshold was chosen between day 2 and 7 to delineate transient from persistent AKI. Conclusions Short-term renal recovery, according to several definitions, was independently associated with higher mortality and RRT requirement. Moreover, distinction between transient and persistent AKI is consequently a clinically relevant surrogate outcome variable for diagnostic testing in critically ill patients.http://link.springer.com/article/10.1186/s13613-018-0467-6Acute kidney injuryIntensive care unitRenal recoveryRenal replacement therapyEpidemiology and outcome
collection DOAJ
language English
format Article
sources DOAJ
author A. S. Truche
S. Perinel Ragey
B. Souweine
S. Bailly
L. Zafrani
L. Bouadma
C. Clec’h
M. Garrouste-Orgeas
G. Lacave
C. Schwebel
F. Guebre-Egziabher
C. Adrie
A. S. Dumenil
Ph. Zaoui
L. Argaud
S. Jamali
D. Goldran Toledano
G. Marcotte
J. F. Timsit
M. Darmon
spellingShingle A. S. Truche
S. Perinel Ragey
B. Souweine
S. Bailly
L. Zafrani
L. Bouadma
C. Clec’h
M. Garrouste-Orgeas
G. Lacave
C. Schwebel
F. Guebre-Egziabher
C. Adrie
A. S. Dumenil
Ph. Zaoui
L. Argaud
S. Jamali
D. Goldran Toledano
G. Marcotte
J. F. Timsit
M. Darmon
ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
Annals of Intensive Care
Acute kidney injury
Intensive care unit
Renal recovery
Renal replacement therapy
Epidemiology and outcome
author_facet A. S. Truche
S. Perinel Ragey
B. Souweine
S. Bailly
L. Zafrani
L. Bouadma
C. Clec’h
M. Garrouste-Orgeas
G. Lacave
C. Schwebel
F. Guebre-Egziabher
C. Adrie
A. S. Dumenil
Ph. Zaoui
L. Argaud
S. Jamali
D. Goldran Toledano
G. Marcotte
J. F. Timsit
M. Darmon
author_sort A. S. Truche
title ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
title_short ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
title_full ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
title_fullStr ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
title_full_unstemmed ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
title_sort icu survival and need of renal replacement therapy with respect to aki duration in critically ill patients
publisher SpringerOpen
series Annals of Intensive Care
issn 2110-5820
publishDate 2018-12-01
description Abstract Background Transient and persistent acute kidney injury (AKI) could share similar physiopathological mechanisms. The objective of our study was to assess prognostic impact of AKI duration on ICU mortality. Design Retrospective analysis of a prospective database via cause-specific model, with 28-day ICU mortality as primary end point, considering discharge alive as a competing event and taking into account time-dependent nature of renal recovery. Renal recovery was defined as a decrease of at least one KDIGO class compared to the previous day. Setting 23 French ICUs. Patients Patients of a French multicentric observational cohort were included if they suffered from AKI at ICU admission between 1996 and 2015. Intervention None. Results A total of 5242 patients were included. Initial severity according to KDIGO creatinine definition was AKI stage 1 for 2458 patients (46.89%), AKI stage 2 for 1181 (22.53%) and AKI stage 3 for 1603 (30.58%). Crude 28-day ICU mortality according to AKI severity was 22.74% (n = 559), 27.69% (n = 327) and 26.26% (n = 421), respectively. Renal recovery was experienced by 3085 patients (58.85%), and its rate was significantly different between AKI severity stages (P < 0.01). Twenty-eight-day ICU mortality was independently lower in patients experiencing renal recovery [CSHR 0.54 (95% CI 0.46–0.63), P < 0.01]. Lastly, RRT requirement was strongly associated with persistent AKI whichever threshold was chosen between day 2 and 7 to delineate transient from persistent AKI. Conclusions Short-term renal recovery, according to several definitions, was independently associated with higher mortality and RRT requirement. Moreover, distinction between transient and persistent AKI is consequently a clinically relevant surrogate outcome variable for diagnostic testing in critically ill patients.
topic Acute kidney injury
Intensive care unit
Renal recovery
Renal replacement therapy
Epidemiology and outcome
url http://link.springer.com/article/10.1186/s13613-018-0467-6
work_keys_str_mv AT astruche icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT sperinelragey icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT bsouweine icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT sbailly icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT lzafrani icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT lbouadma icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT cclech icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT mgarrousteorgeas icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT glacave icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT cschwebel icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT fguebreegziabher icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT cadrie icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT asdumenil icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT phzaoui icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT largaud icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT sjamali icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT dgoldrantoledano icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT gmarcotte icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT jftimsit icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
AT mdarmon icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients
_version_ 1724723068053487616